Antimyeloperoxidase antibodies and adverse reactions to clozapine
- 27 June 1992
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 339 (8809), 1611-1612
- https://doi.org/10.1016/0140-6736(92)91877-b
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Metabolism of Clozapine† by NeutrophilsDrug Safety, 1992
- Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupusClinical and Experimental Immunology, 1990
- Association of autoantibodies to myeloperoxidase with different forms of vasculitisArthritis & Rheumatism, 1990
- Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro.Proceedings of the National Academy of Sciences, 1990
- Drug Metabolism by Leukocytes and Its Role in Drug-Induced Lupus and Other Idiosyncratic Drug ReactionsCritical Reviews in Toxicology, 1990
- The Immunologic and Metabolic Basis of Drug HypersensitivitiesAnnual Review of Pharmacology and Toxicology, 1988
- Neutrophil Pseudoplatelets: Their Discrimination by Myeloperoxidase DemonstrationScience, 1983
- Agranulocytosis during treatment with clozapineEuropean Journal of Clinical Pharmacology, 1977